How much funding has Felix Biotechnology raised?

Felix Biotechnology has raised $150K in total funding, most recently a Grant round.

When was Felix Biotechnology founded?

Felix Biotechnology was founded in 2019.

Where is Felix Biotechnology headquartered?

Felix Biotechnology is headquartered in San Francisco, California, United States.

What industry is Felix Biotechnology in?

Felix Biotechnology operates in Biotech, Genomics, Healthcare, Therapeutics.

How many employees does Felix Biotechnology have?

Felix Biotechnology has 1-10 employees.

Felix Biotechnology

Q: Who are Felix Biotechnology's investors?

Felix Biotechnology's investors include Small Business Innovation Research, Cystic Fibrosis Foundation.

Closed

We’re creating programmable therapies

San Francisco, United States · Founded 2019 · $150K raised

YC W20

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2019
Website: felixbt.com

Total Funding: $150K
Last Round: $150K GrantMar 2020
Rounds: 1

About

We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.

Summary

Felix Biotechnology is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $150K in total across 1 round, most recently a $150K Grant round in Mar 2020. Investors include Small Business Innovation Research and Cystic Fibrosis Foundation.

Funding History

GrantMar 2020

$150K

Mar 2020

Investors

Small Business Innovation Research

1 round

Cystic Fibrosis Foundation

1 round

Similar Companies

Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics

Corporate Round·$1.0B·Apr 2020

Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare

Series D·$1.4B·Jun 2020

Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, China201–500Biotech, mRNA Therapeutics

Extension Round·$1.3B·Nov 2021

Ultima Genomics

Novel DNA sequencing architecture to scale the ultra low cost whole genome

Fremont, United States201–500Artificial Intelligence, Healthcare

Series E·$1.1B·Jun 2022

ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences

Series C·$955.0M·Sep 2024

Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare

Venture Round·$884.0M·Jul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

<a href="https://indexed.vc/companies/felix-biotechnology"><img src="https://indexed.vc/api/badge/company/felix-biotechnology" alt="Felix Biotechnology on Indexed.vc" width="260" height="76" /></a>